You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
據報河南714種集採藥品平均降幅逾五成 142種醫用耗材平均降幅近八成
據內地媒體《界面新聞》從河南省醫療保障局獲悉,全省積極推進藥品醫用耗材集中帶量採購提速擴面,降低藥品醫用耗材虛高價格水分,714種集採藥品平均降幅超過50%,142種醫用耗材降幅近80%,切實減輕群眾醫藥負擔。 集採後,高血壓、高血脂、糖尿病藥品價格大幅下降,平均每片降至0.2元人民幣(下同)左右,病人每月藥品費用降至10元以內;治療乙肝用藥恩替卡韋由每片10.8元降至0.2元,每人年治療費用由3,942元降至73元;冠脈支架價格由平均1.3萬元降至700元左右,病人人均費用由5.48萬元降至3.22萬元;人工髖關節由平均3.5萬元降至平均7,000元,置換病人人均費用由4.9萬元降至2.38萬元。 目前,河南省正牽頭開展19省藥品聯盟採購,計劃本月完成採購工作,還牽頭開展神經外科耗材20省聯盟和通用介入類耗材18省聯盟採購,目前已完成多輪次企業意見徵求會,計劃月底前產生中選結果。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account